Our trusted patient education publications and website contain comprehensive and reliable information about cancer, treatment facilities, support groups, and links to other informative websites.
Get a Free copy Today!
Here is an inspiring, but poignant story by a legacy in golf, Arnold Palmer, a 14 year prostate cancer survivor. Cancer has ravaged his family, as it does in many others. His wife, Winny, died of ovarian cancer in 1999, and his daughter had breast cancer at age 32, but who is living today over 15 years later!
Arnold Palmer has been a great spokesman for cancer, is a dedicated cancer survivor, and has “given back” to the cancer community with the many cancer programs and buildings he has funded. You’ll enjoy his story!
Here’s more information from our companion website, patientresource.net:
With the widespread use of prostate-specific antigen (PSA) testing to identify men at increased risk of prostate cancer, more individuals have been diagnosed with prostate cancer than in the period before PSA testing was widely available (pre-1992). Cancers diagnosed through PSA testing are often early stage or less advanced cancers. According to data from the National Cancer Institute, more than 90 percent of all prostate cancers are now diagnosed at a less advanced stage and men are surviving longer after diagnosis and treatment.
PSA is a widely used biological marker, or biomarker, of prostate cancer risk. A lot of research is currently being done to identify other biomarkers of risk that may enhance the predictive value of nomograms and improve a physician’s ability to predict capsular penetration and distant metastasis (spread) of prostate cancer, as well as cancer recurrence after treatment. A nomogram, as defined by the National Cancer Institute, is a mathematical device or model that shows relationships between things. For example, a nomogram of height and weight measurements can be used to find the surface area of a person, without doing the math, to determine the right dose of chemotherapy. Nomograms of patient and disease characteristics can help predict the outcome of some kinds of cancer.
Once prostate cancer is diagnosed, you and your doctor must go through a process of risk assessment, estimating the likelihood that your cancer has or may spread outside the prostate and assessing your risk of disease recurrence after treatment. This assessment combined with characteristics of your overall health will allow your doctor to advise which treatment option will benefit you the most. Your doctor will use factors such as your Gleason score, PSA level, tumor stage and the number of tumor samples (called cores) taken by biopsy that are positive for cancer.